BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 32 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | -99.5% | 2,000 | -99.7% | 0.00% | – |
| Q1 2020 | $616,000 | +1953.3% | 591,000 | +2010.7% | 0.00% | – |
| Q4 2019 | $30,000 | +87.5% | 28,000 | +75.0% | 0.00% | – |
| Q3 2019 | $16,000 | -97.2% | 16,000 | -96.9% | 0.00% | – |
| Q2 2019 | $576,000 | -66.2% | 516,000 | -65.6% | 0.00% | – |
| Q1 2019 | $1,706,000 | -30.9% | 1,500,000 | -31.9% | 0.00% | -100.0% |
| Q4 2018 | $2,468,000 | -14.1% | 2,204,000 | -8.3% | 0.00% | 0.0% |
| Q3 2018 | $2,872,000 | +16794.1% | 2,404,000 | +15926.7% | 0.00% | – |
| Q2 2018 | $17,000 | -99.6% | 15,000 | -99.6% | 0.00% | -100.0% |
| Q1 2018 | $3,875,000 | +339.3% | 3,514,000 | +371.0% | 0.00% | – |
| Q4 2017 | $882,000 | +4800.0% | 746,000 | +4873.3% | 0.00% | – |
| Q3 2017 | $18,000 | +5.9% | 15,000 | +7.1% | 0.00% | – |
| Q2 2017 | $17,000 | +70.0% | 14,000 | +75.0% | 0.00% | – |
| Q1 2017 | $10,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q4 2016 | $10,000 | -85.1% | 8,000 | -85.2% | 0.00% | – |
| Q3 2016 | $67,000 | +116.1% | 54,000 | +100.0% | 0.00% | – |
| Q2 2016 | $31,000 | -83.3% | 27,000 | -82.8% | 0.00% | – |
| Q1 2016 | $186,000 | -7.0% | 157,000 | +4.7% | 0.00% | – |
| Q4 2015 | $200,000 | +13.0% | 150,000 | +13.6% | 0.00% | – |
| Q3 2015 | $177,000 | +2850.0% | 132,000 | +3200.0% | 0.00% | – |
| Q2 2015 | $6,000 | -100.0% | 4,000 | -100.0% | 0.00% | -100.0% |
| Q1 2015 | $15,813,000 | +23.2% | 10,568,000 | +0.0% | 0.01% | +20.0% |
| Q4 2014 | $12,839,000 | +38.2% | 10,567,000 | +24.1% | 0.01% | +25.0% |
| Q3 2014 | $9,292,000 | -10.6% | 8,515,000 | -14.4% | 0.00% | 0.0% |
| Q2 2014 | $10,392,000 | -5.7% | 9,944,000 | 0.0% | 0.00% | -20.0% |
| Q1 2014 | $11,025,000 | +39.2% | 9,944,000 | +35.0% | 0.01% | +66.7% |
| Q4 2013 | $7,921,000 | – | 7,368,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |